Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents

Circulation

Volumn 125, Issue 21, 2012, Pages 2621-2629

  Leslie, Laurel K ^a,b   Cohen, Joshua T ^a   Newburger, Jane W ^c   Alexander, Mark E ^c   Wong, John B ^b   Sherwin, Elizabeth D ^c   Rodday, Angie Mae ^a   Parsons, Susan K ^a,b   Triedman, John K ^c  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

cardiomyopathies; electrocardiography; long QT syndrome; pediatrics; Wolff Parkinson White syndrome

Indexed keywords

ADOLESCENT; ALGORITHM; ARTICLE; ATTENTION DEFICIT DISORDER; CARDIOVASCULAR MORTALITY; CHILD; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ELECTROCARDIOGRAM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LIFE EXPECTANCY; LONG QT SYNDROME; MEDICAID; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SCREENING; SENSITIVITY AND SPECIFICITY; SIMULATION; SUDDEN DEATH; WOLFF PARKINSON WHITE SYNDROME;

ADOLESCENT; ATHLETIC INJURIES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; DEATH, SUDDEN, CARDIAC; HUMANS; MASS SCREENING; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84861625007     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.087940     Document Type: Article

References (29)

1. Berger S, Utech L, Fran HM. Sudden death in children and adolescents. Pediatr Clin North Am. 2004;51:1653-1677. (Pubitemid 39550508)
2. Tanaka Y, Yoshinaga M, Anan R, Tanaka Y, Nomura Y, Oku S, Nishi S, Kawano Y, Tei C, Arima K, Tanaka Y, Yoshinaga M, Anan R, Tanaka Y, Nomura Y, Oku S, Nishi S, Kawano Y, Tei C, Arima K. Usefulness and cost effectiveness of cardiovascular screening of young adolescents. Med Sci Sports Exerc. 2006;38:2-6. (Pubitemid 43062949)
3. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296: 1593-1601. (Pubitemid 44515020)
4. Steinvil A, Chundadze T, Zeltser D, Rogowski O, Halkin A, Galily Y, Perluk H, Viskin S. Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death: proven fact or wishful thinking? J Am Coll Cardiol. 2011;57:1291-1296.
5. Baggish AL, Hutter AM Jr, Wang F, Yared K, Weiner RB, Kupperman E, Picard MH, Wood MJ. Cardiovascular screening in college athletes with and without electrocardiography: a cross-sectional study. Ann Intern Med. 2010;152:269-275.
6. Bove A. Making or breaking athletic careers. J Am Coll Cardiol. 2011; 57:1297-1298.
7. Vetter VL, Dugan N, Guo R, Mercer-Rosa L, Gleason M, Cohen M, Vogel RL, Iyer R. A pilot study of the feasibility of heart screening for sudden cardiac arrest in healthy children. Am Heart J. 2011;161: 1000-1006.
8. Kaltman JR, Thompson P, Lantos J, Berul C, Cohen J, Cook N, Drezner J, Frick K, Kannankeril P, Leslie L, Priori S, Saul J, Shapiro-Mendoza C, Siscovick D, Vetter V, Botkin J, Corrado D, Goldman S, Hlatky M, Boineau R, Burns K, Friedman R. Screening for sudden cardiac death in the young: report from a National Heart, Lung, and Blood Institute Working Group. Circulation. 2011;123:1911-1918.
9. Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, Dimeff R, Douglas PS, Glover DW, Hutter AM Jr, Krauss MD, Maron MS, Mitten MJ, Roberts WO, Puffer JC. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007;115:1643-455.
10. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339:364-369. (Pubitemid 28363798)
11. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA. 1996;276:199-204. (Pubitemid 26235063)
12. Marek J, Bufalino V, Davis J, Marek K, Gami A, Stephan W, Zimmerman F. Feasibility and findings of large-scale electrocardiographic screening in young adults: data from 32,561 subjects. Heart Rhythm. 2011;10:1555-1559.
13. Fuller C. Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc. 2000;32:87-90.
14. Wheeler MT, Heidenreich PA, Froelicher VF, Hlatky MA, Ashley EA. Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med. 2010;152:276-286.
15. Denchev P, Kaltman JR, Schoenbaum M, Vitiello B. Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/hyperactivity disorder. Circulation. 2010;121:1329-1337.
16. Rodday AM, Triedman JK, Alexander ME, Cohen JT, Ip S, Newburger JW, Parsons SK, Trikalinos TA, Wong JB, Leslie LK. Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis. Pediatrics. 2012;129:e999-e1010.
17. Center for Disease Control. Diagnosed Attention Deficit Hyperactivity Disorder and Learning Disability: United States, 2004-2006. Washington, DC: US Department of Health and Human Services; 2008.
18. National Federation of State High School Associations. High school sports participation continues upward climb. http://www.nfhs.org/content.aspx?id-5752. Accessed September 3, 2011.
19. Davis J, Bauman K. School Enrollment in the United States: 2008. Washington, DC: US Census Bureau; 2011.
20. American Academy of Pediatrics/American Heart Association. American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD. www.aap.org/pressroom/aap-ahastatement. htm2011. Accessed February 14, 2011.
21. Gold M. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
22. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276:1253-1258. (Pubitemid 26337709)
23. Kuntz KM, Weinstein MC. Modelling in Economic Evaluation. In: Drummond M, McGuire A, eds. Economic Evaluation in Health Care: Merging Theory with Practice. New York, NY: Oxford University Press; 2001.
24. Hill AC, Miyake CY, Grady S, Dubin AM. Accuracy of Interpretation of Preparticipation Screening Electrocardiograms. J Pediatr. 2011;159:783-788.
25. Schelleman H, Bilker WB, Strom BL, Kimmel SE, Newcomb C, Guevara JP, Daniel GW, Cziraky MJ, Hennessy S. Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics. 2011;127:1102-1110.
26. Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med. 2011;365:1896-1904.
27. Estes NA 3rd. ECG screening for athletes: letting evidence and reason advance the debate. Heart Rhythm. 2011;8:728-730.
28. Bergman AB, Stamm SJ. The morbidity of cardiac nondisease in schoolchildren. N Engl J Med. 1967;276:1008-1013.
29. Chapman RH, Berger M, Weinstein MC, Weeks JC, Goldie S, Neumann PJ. When does quality-adjusting life-years matter in cost-effectiveness analysis? Health Econ. 2004;13:429-436. (Pubitemid 38660392)